← Back
Data updated: Mar 10, 2026
DAVA PHARMS INC
CardiovascularNeurologyGastroenterology
DAVA PHARMS INC is a generic drug manufacturer focused on Cardiovascular, Neurology, Gastroenterology.
1979
Since
17
Drugs
-
Trials
191
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
PROPRANOLOL HYDROCHLORIDE 2026-01-27
MORPHINE SULFATE 2025-12-22
Labeling
MORPHINE SULFATE 2025-12-22
Labeling
MORPHINE SULFATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
MORPHINE SULFATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
2 drugs
Neurology 25%
1 drugs
Gastroenterology 25%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Discontinued (13)
Company Info
- First Approval
- 1979-08-29
- Latest
- 2023-10-23
- Applications
- 41